Points to Consider on Adjustment for Baseline Covariatesへの意見

• 萩野 篤司

  持田製薬株式会社

書誌事項

タイトル別名

• Comments on “Points to Consider on Adjustment for Baseline Covariates”
• Points to Consider on Adjustment for Baseline Covariates エ ノ イケン

抄録

In May 2003, the Committee for Proprietary Medicinal Products (CPMP) of the European Agency for the Evaluation of Medicinal Products (EMEA) issued a guidance regarding the adjustment for covariates entitled “Points to Consider on Adjustment for Baseline Covariates”. This article provides a summary of the guidance and specifically discusses the use of dynamic allocation from the viewpoint that advocates the necessity of pre-stratification in clinical trials.

収録刊行物

• 計量生物学

  計量生物学 27 (Special_Issue), S8-S15, 2006

  日本計量生物学会

キーワード

• CPMP
• Points to Consider
• Covariates
• dynamic allocation

詳細情報

• CRID: 1390282679345220608
• NII論文ID: 10018357431
• NII書誌ID: AA11591618
• DOI: 10.5691/jjb.27.s8
• ISSN: 21856494
• ISSN: 09184430
• NDL書誌ID: 8532372
• Web Site: https://ndlsearch.ndl.go.jp/books/R000000004-I8532372
• データソース種別:
  • JaLC
  • NDL
  • Crossref
  • CiNii Articles
• 抄録ライセンスフラグ: 使用不可